BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21062201)

  • 1. Self-reported changes in providers' hormone therapy prescribing and counseling practices after the Women's Health Initiative.
    Lakey SL; Reed SD; LaCroix AZ; Grothaus L; Newton KM
    J Womens Health (Larchmt); 2010 Dec; 19(12):2175-81. PubMed ID: 21062201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing of FDA-approved and compounded hormone therapy differs by specialty.
    Constantine GD; Archer DF; Graham S; Bernick BA; Mirkin S
    Menopause; 2016 Oct; 23(10):1075-82. PubMed ID: 27648594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provider attributes associated with hormone therapy prescribing frequency.
    Spangler L; Reed SD; Nekhyludov L; Grothaus LC; LaCroix AZ; Newton KM
    Menopause; 2009; 16(4):810-16. PubMed ID: 19407679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge and personal use of menopausal hormone therapy among Chinese obstetrician-gynecologists: results of a survey.
    Wang Y; Yang X; Li X; He X; Zhao Y
    Menopause; 2014 Nov; 21(11):1190-6. PubMed ID: 24736196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer screening practices among obstetrician/gynecologists and nurse practitioners.
    Menees SB; Patel DA; Dalton V
    J Womens Health (Larchmt); 2009 Aug; 18(8):1233-8. PubMed ID: 19630544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of multiple providers for regular care and women's receipt of hormone replacement therapy counseling.
    Gallagher TC; Geling O; Comite F
    Med Care; 2001 Oct; 39(10):1086-96. PubMed ID: 11567171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and Ethnic Disparities in Cardiovascular Disease: An Assessment of Obstetrician-Gynecologists' Knowledge, Attitudes, and Practice Patterns.
    Jones KM; Carter MM; Schulkin J
    J Racial Ethn Health Disparities; 2015 Jun; 2(2):256-66. PubMed ID: 26863341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge of clinical trials regarding hormone therapy and likelihood of prescribing hormone therapy.
    Taylor HS; Kagan R; Altomare CJ; Cort S; Bushmakin AG; Abraham L
    Menopause; 2017 Jan; 24(1):27-34. PubMed ID: 27575548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing Bioidentical Menopausal Hormone Therapy: A Survey of Physician Views and Practices.
    Dubaut JP; Dong F; Tjaden BL; Grainger DA; Duong J; Tatpati LL
    J Womens Health (Larchmt); 2018 Jul; 27(7):859-866. PubMed ID: 29583064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era.
    Nassar AH; Abd Essamad HM; Awwad JT; Khoury NG; Usta IM
    Maturitas; 2005 Sep; 52(1):18-25. PubMed ID: 16143222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How the Women's Health Initiative (WHI) influenced physicians' practice and attitudes.
    Bush TM; Bonomi AE; Nekhlyudov L; Ludman EJ; Reed SD; Connelly MT; Grothaus LC; LaCroix AZ; Newton KM
    J Gen Intern Med; 2007 Sep; 22(9):1311-6. PubMed ID: 17634782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female Pelvic Medicine and Reconstructive Surgery in Canada: A Survey of Obstetrician-Gynecologists and Urologists.
    Christakis MK; Shore EM; Pulver A; McDermott CD
    Female Pelvic Med Reconstr Surg; 2017; 23(3):195-203. PubMed ID: 27918338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What we don't talk about when we don't talk about sex: results of a national survey of U.S. obstetrician/gynecologists.
    Sobecki JN; Curlin FA; Rasinski KA; Lindau ST
    J Sex Med; 2012 May; 9(5):1285-94. PubMed ID: 22443146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy.
    Power ML; Zinberg S; Schulkin J
    Menopause; 2006; 13(3):434-41. PubMed ID: 16735940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes of obstetrician-gynecologists toward the evidence from the Women's Health Initiative hormone therapy trials remain generally skeptical.
    Power ML; Anderson BL; Schulkin J
    Menopause; 2009; 16(3):500-8. PubMed ID: 19169162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
    Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
    Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal Contraceptives for Endometrial Cancer Prevention in Obese and High-Risk Women in Virginia.
    Horst KE; Modesitt SC
    South Med J; 2016 Oct; 109(10):621-627. PubMed ID: 27706499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic Health Record Adoption among Obstetrician/Gynecologists in the United States: Physician Practices and Satisfaction.
    Raglan GB; Margolis B; Paulus RA; Schulkin J
    J Healthc Qual; 2017; 39(3):144-152. PubMed ID: 28481842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone therapy discontinuation: physician practices after the Women's Health Initiative.
    Newton KM; Reed SD; Grothaus LC; La Croix AZ; Nekhlyudov L; Ehrlich K; Ludman EJ
    Menopause; 2010 Jul; 17(4):734-40. PubMed ID: 20445466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.